Wegovy's Fast Weight Loss Comes with a Catch—Stopping Reverses Gains

Semaglutide, sold under the brand Wegovy®, has shown rapid and lasting effects for weight loss and health improvements. Within the first month, users often experience better blood sugar control, reduced cravings, and a faster metabolism. Long-term use can also cut the risk of serious heart problems and help maintain significant weight loss over years. The drug begins working quickly. In the first four weeks, it lowers blood sugar levels, increases feelings of fullness, and quiets persistent 'food noise'—the constant thoughts about eating. Metabolism also gets a boost during this early period.

After a year, many people with obesity lose between 15% and 25% of their body weight. However, stopping the medication often leads to weight regain. Studies show that 23% of users who quit semaglutide after two years returned to their original weight. More than half of those who stopped after one year either kept the weight off or lost more, but the risk of rebound remains high. For lasting results, experts recommend staying on GLP-1 drugs like semaglutide for at least two years. Beyond weight loss, long-term use over four years has been linked to fewer heart attacks, strokes, and other cardiovascular events.

Semaglutide offers fast and measurable benefits, from curbing cravings to improving heart health. Yet its effects depend on continued use, as stopping often reverses progress. The drug’s ability to sustain weight loss and protect against serious illness makes it a key option for long-term obesity management.